Skip to main content
PMC home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1998 Jan;152(1):279–287.

Two novel antifibrotics, HOE 077 and Safironil, modulate stellate cell activation in rat liver injury: differential effects in males and females.

Y J Wang 1, S S Wang 1, M Bickel 1, V Guenzler 1, M Gerl 1, D M Bissell 1
PMCID: PMC1858123  PMID: 9422545

Abstract

The perisinusoidal stellate cells of the liver in an injury milieu undergo activation, acquiring a myofibroblast-like phenotype. In this state, they are the principal source of collagen and related proteins in fibrosis. The present studies evaluate the mechanism of action of two novel antifibrotic compounds, HOE 077 and Safironil, which were designed as competitive inhibitors of collagen protein synthesis. Fibrosis was induced in rats by administration of carbon tetrachloride, and activation was monitored as the level of collagen I mRNA or smooth muscle alpha-actin. Both male and female rats were studied. Stellate cell activation, rather than collagen synthesis, proved to be the target of both HOE 077 and Safironil in the intact liver. In culture, the drugs not only prevented the activation of stellate cells but also accelerated their deactivation. They were no more effective in co-cultures containing hepatocytes than in pure stellate cell cultures, indicating that metabolic conversion of HOE 077 was not required. Interestingly, the response of cells from females was greater than that of male cells, leading to the conclusion that stellate activation is sexually dimorphic. This finding may be relevant to the observation that fibrosis in chronic viral hepatitis progresses less rapidly and that hepatocellular carcinoma is less frequent in females than in males.

Full text

PDF
279

Images in this article

281Figure 1
on p.281
283Figure 2
on p.283
285Figure 7
on p.285

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abdel-Aziz G., Lebeau G., Rescan P. Y., Clément B., Rissel M., Deugnier Y., Campion J. P., Guillouzo A. Reversibility of hepatic fibrosis in experimentally induced cholestasis in rat. Am J Pathol. 1990 Dec;137(6):1333–1342. [PMC free article] [PubMed] [Google Scholar]
  2. Bayard F., Clamens S., Meggetto F., Blaes N., Delsol G., Faye J. C. Estrogen synthesis, estrogen metabolism, and functional estrogen receptors in rat arterial smooth muscle cells in culture. Endocrinology. 1995 Apr;136(4):1523–1529. doi: 10.1210/endo.136.4.7895662. [DOI] [PubMed] [Google Scholar]
  3. Becker U., Deis A., Sørensen T. I., Grønbaek M., Borch-Johnsen K., Müller C. F., Schnohr P., Jensen G. Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study. Hepatology. 1996 May;23(5):1025–1029. doi: 10.1002/hep.510230513. [DOI] [PubMed] [Google Scholar]
  4. Bickel M., Baader E., Brocks D. G., Engelbart K., Günzler V., Schmidts H. L., Vogel G. H. Beneficial effects of inhibitors of prolyl 4-hydroxylase in CCl4-induced fibrosis of the liver in rats. J Hepatol. 1991;13 (Suppl 3):S26–S34. doi: 10.1016/0168-8278(91)90005-v. [DOI] [PubMed] [Google Scholar]
  5. Bissell D. M., Caron J. M., Babiss L. E., Friedman J. M. Transcriptional regulation of the albumin gene in cultured rat hepatocytes. Role of basement-membrane matrix. Mol Biol Med. 1990 Apr;7(2):187–197. [PubMed] [Google Scholar]
  6. Brocks D. G., Bickel M., Engelbart K. Type IV collagen antigens in serum of rats with experimental fibrosis of the liver. Alcohol Alcohol Suppl. 1987;1:497–500. [PubMed] [Google Scholar]
  7. Brocks D. G., Steinert C., Gerl M., Knolle J., Neubauer H. P., Günzler V. A radioimmunoassay for the N-terminal propeptide of rat procollagen type III. Application to the study of the uptake of the N-terminal propeptide of procollagen type III in isolated perfused rat liver. Matrix. 1993 Sep;13(5):381–387. doi: 10.1016/s0934-8832(11)80043-0. [DOI] [PubMed] [Google Scholar]
  8. Chen C. J., Liang K. Y., Chang A. S., Chang Y. C., Lu S. N., Liaw Y. F., Chang W. Y., Sheen M. C., Lin T. M. Effects of hepatitis B virus, alcohol drinking, cigarette smoking and familial tendency on hepatocellular carcinoma. Hepatology. 1991 Mar;13(3):398–406. [PubMed] [Google Scholar]
  9. Chu C. M., Sheen I. S., Lin S. M., Liaw Y. F. Sex difference in chronic hepatitis B virus infection: studies of serum HBeAg and alanine aminotransferase levels in 10,431 asymptomatic Chinese HBsAg carriers. Clin Infect Dis. 1993 May;16(5):709–713. doi: 10.1093/clind/16.5.709. [DOI] [PubMed] [Google Scholar]
  10. Clément B., Chesné C., Satie A. P., Guillouzo A. Effects of the prolyl 4-hydroxylase proinhibitor HOE 077 on human and rat hepatocytes in primary culture. J Hepatol. 1991;13 (Suppl 3):S41–S47. doi: 10.1016/0168-8278(91)90007-x. [DOI] [PubMed] [Google Scholar]
  11. Friedman S. L., Roll F. J., Boyles J., Bissell D. M. Hepatic lipocytes: the principal collagen-producing cells of normal rat liver. Proc Natl Acad Sci U S A. 1985 Dec;82(24):8681–8685. doi: 10.1073/pnas.82.24.8681. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Friedman S. L. Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N Engl J Med. 1993 Jun 24;328(25):1828–1835. doi: 10.1056/NEJM199306243282508. [DOI] [PubMed] [Google Scholar]
  13. Gotwals P. J., Chi-Rosso G., Lindner V., Yang J., Ling L., Fawell S. E., Koteliansky V. E. The alpha1beta1 integrin is expressed during neointima formation in rat arteries and mediates collagen matrix reorganization. J Clin Invest. 1996 Jun 1;97(11):2469–2477. doi: 10.1172/JCI118693. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Guattery J. M., Faloon W. W., Biery D. L. Effect of ethinyl estradiol on chronic active hepatitis. Ann Intern Med. 1996 Oct 15;125(8):700–700. doi: 10.7326/0003-4819-125-8-199610150-00028. [DOI] [PubMed] [Google Scholar]
  15. Hanauske-Abel H. M., Günzler V. A stereochemical concept for the catalytic mechanism of prolylhydroxylase: applicability to classification and design of inhibitors. J Theor Biol. 1982 Jan 21;94(2):421–455. doi: 10.1016/0022-5193(82)90320-4. [DOI] [PubMed] [Google Scholar]
  16. Housset C., Rockey D. C., Bissell D. M. Endothelin receptors in rat liver: lipocytes as a contractile target for endothelin 1. Proc Natl Acad Sci U S A. 1993 Oct 15;90(20):9266–9270. doi: 10.1073/pnas.90.20.9266. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Jarnagin W. R., Rockey D. C., Koteliansky V. E., Wang S. S., Bissell D. M. Expression of variant fibronectins in wound healing: cellular source and biological activity of the EIIIA segment in rat hepatic fibrogenesis. J Cell Biol. 1994 Dec;127(6 Pt 2):2037–2048. doi: 10.1083/jcb.127.6.2037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Kershenobich D., Vargas F., Garcia-Tsao G., Perez Tamayo R., Gent M., Rojkind M. Colchicine in the treatment of cirrhosis of the liver. N Engl J Med. 1988 Jun 30;318(26):1709–1713. doi: 10.1056/NEJM198806303182602. [DOI] [PubMed] [Google Scholar]
  19. Knittel T., Schuppan D., Meyer zum Büschenfelde K. H., Ramadori G. Differential expression of collagen types I, III, and IV by fat-storing (Ito) cells in vitro. Gastroenterology. 1992 May;102(5):1724–1735. doi: 10.1016/0016-5085(92)91736-n. [DOI] [PubMed] [Google Scholar]
  20. López-De León A., Rojkind M. A simple micromethod for collagen and total protein determination in formalin-fixed paraffin-embedded sections. J Histochem Cytochem. 1985 Aug;33(8):737–743. doi: 10.1177/33.8.2410480. [DOI] [PubMed] [Google Scholar]
  21. Maher J. J., McGuire R. F. Extracellular matrix gene expression increases preferentially in rat lipocytes and sinusoidal endothelial cells during hepatic fibrosis in vivo. J Clin Invest. 1990 Nov;86(5):1641–1648. doi: 10.1172/JCI114886. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Maher J. J., Zia S., Tzagarakis C. Acetaldehyde-induced stimulation of collagen synthesis and gene expression is dependent on conditions of cell culture: studies with rat lipocytes and fibroblasts. Alcohol Clin Exp Res. 1994 Apr;18(2):403–409. doi: 10.1111/j.1530-0277.1994.tb00033.x. [DOI] [PubMed] [Google Scholar]
  23. Mak K. M., Leo M. A., Lieber C. S. Alcoholic liver injury in baboons: transformation of lipocytes to transitional cells. Gastroenterology. 1984 Jul;87(1):188–200. [PubMed] [Google Scholar]
  24. Morcos S. H., Khayyal M. T., Mansour M. M., Saleh S., Ishak E. A., Girgis N. I., Dunn M. A. Reversal of hepatic fibrosis after praziquantel therapy of murine schistosomiasis. Am J Trop Med Hyg. 1985 Mar;34(2):314–321. doi: 10.4269/ajtmh.1985.34.314. [DOI] [PubMed] [Google Scholar]
  25. Mullins D. E., Hamud F., Reim R., Davis H. R. Inhibition of PDGF receptor binding and PDGF-stimulated biological activity in vitro and of intimal lesion formation in vivo by 2-bromomethyl-5-chlorobenzene sulfonylphthalimide. Arterioscler Thromb. 1994 Jul;14(7):1047–1055. doi: 10.1161/01.atv.14.7.1047. [DOI] [PubMed] [Google Scholar]
  26. Palmerini C. A., Fini C., Floridi A., Morelli H., Vedovelli A. High-performance liquid chromatographic analysis of free hydroxyproline and proline in blood plasma and of free and peptide-bound hydroxyproline in urine. J Chromatogr. 1985 May 3;339(2):285–292. doi: 10.1016/s0378-4347(00)84655-1. [DOI] [PubMed] [Google Scholar]
  27. Pinzani M., Failli P., Ruocco C., Casini A., Milani S., Baldi E., Giotti A., Gentilini P. Fat-storing cells as liver-specific pericytes. Spatial dynamics of agonist-stimulated intracellular calcium transients. J Clin Invest. 1992 Aug;90(2):642–646. doi: 10.1172/JCI115905. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Poynard T., Bedossa P., Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet. 1997 Mar 22;349(9055):825–832. doi: 10.1016/s0140-6736(96)07642-8. [DOI] [PubMed] [Google Scholar]
  29. Prockop D. J., Kivirikko K. I. Collagens: molecular biology, diseases, and potentials for therapy. Annu Rev Biochem. 1995;64:403–434. doi: 10.1146/annurev.bi.64.070195.002155. [DOI] [PubMed] [Google Scholar]
  30. Resnick R. H., Koff R. Hepatitis C-related hepatocellular carcinoma. Prevalence and significance. Arch Intern Med. 1993 Jul 26;153(14):1672–1677. [PubMed] [Google Scholar]
  31. Rhoads D. D., Dixit A., Roufa D. J. Primary structure of human ribosomal protein S14 and the gene that encodes it. Mol Cell Biol. 1986 Aug;6(8):2774–2783. doi: 10.1128/mcb.6.8.2774. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Rockey D. C., Boyles J. K., Gabbiani G., Friedman S. L. Rat hepatic lipocytes express smooth muscle actin upon activation in vivo and in culture. J Submicrosc Cytol Pathol. 1992 Apr;24(2):193–203. [PubMed] [Google Scholar]
  33. Rockey D. C., Chung J. J. Interferon gamma inhibits lipocyte activation and extracellular matrix mRNA expression during experimental liver injury: implications for treatment of hepatic fibrosis. J Investig Med. 1994 Dec;42(4):660–670. [PubMed] [Google Scholar]
  34. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993 Apr 29;362(6423):801–809. doi: 10.1038/362801a0. [DOI] [PubMed] [Google Scholar]
  35. Sakaida I., Matsumura Y., Kubota M., Kayano K., Takenaka K., Okita K. The prolyl 4-hydroxylase inhibitor HOE 077 prevents activation of Ito cells, reducing procollagen gene expression in rat liver fibrosis induced by choline-deficient L-amino acid-defined diet. Hepatology. 1996 Apr;23(4):755–763. doi: 10.1053/jhep.1996.v23.pm0008666329. [DOI] [PubMed] [Google Scholar]
  36. Schuppan D. Structure of the extracellular matrix in normal and fibrotic liver: collagens and glycoproteins. Semin Liver Dis. 1990 Feb;10(1):1–10. doi: 10.1055/s-2008-1040452. [DOI] [PubMed] [Google Scholar]
  37. Strauss B. H., Chisholm R. J., Keeley F. W., Gotlieb A. I., Logan R. A., Armstrong P. W. Extracellular matrix remodeling after balloon angioplasty injury in a rabbit model of restenosis. Circ Res. 1994 Oct;75(4):650–658. doi: 10.1161/01.res.75.4.650. [DOI] [PubMed] [Google Scholar]
  38. Sullivan T. R., Jr, Karas R. H., Aronovitz M., Faller G. T., Ziar J. P., Smith J. J., O'Donnell T. F., Jr, Mendelsohn M. E. Estrogen inhibits the response-to-injury in a mouse carotid artery model. J Clin Invest. 1995 Nov;96(5):2482–2488. doi: 10.1172/JCI118307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Vater C. A., Harris E. D., Jr, Siegel R. C. Native cross-links in collagen fibrils induce resistance to human synovial collagenase. Biochem J. 1979 Sep 1;181(3):639–645. doi: 10.1042/bj1810639. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Wang Y. J., Lee S. D., Hsieh M. C., Lin H. C., Lee F. Y., Tsay S. H., Tsai Y. T., Hu O. Y., King M. L., Lo K. J. A double-blind randomized controlled trial of colchicine in patients with hepatitis B virus-related postnecrotic cirrhosis. J Hepatol. 1994 Nov;21(5):872–877. doi: 10.1016/s0168-8278(94)80252-1. [DOI] [PubMed] [Google Scholar]
  41. Wu J., Danielsson A. Inhibition of hepatic fibrogenesis: a review of pharmacologic candidates. Scand J Gastroenterol. 1994 May;29(5):385–391. doi: 10.3109/00365529409096827. [DOI] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES